MXene Ti3C2 Nb2C V2C MOF Nb2C Two dimensional materials

Nanomedicine

Nanomedicine - Cosmetic Surgery
Nanomedicine - Burn Department
Nanomedicine — Urology
Nanomedicine—Orthopedics
Nanomedicine—Hepatobiliary and Pancreatic Surgery
Nanomedicine - Vascular Surgery
Nanomedicine — Gastrointestinal Surgery
Nanomedicine—Head and Neck Surgery
Nanomedicine - Hematology
Nanomedicine - Rheumatology and Immunology
Nanomedicine - Neurology
Nanomedicine—Respiratory
Nanomedicine—Digestive
Nanomedicine - General Internal Medicine
Nanomedicine - Endocrinology
Nanomedicine - Tumors
Nanomedicine - Cardiovascular
Beike Material Computing Service
Frontiers of Material Computing
Material customization

hotline：

17715390137

Tel/Wechat：

18101240246 (Technology)

0512-68565571

Email：mxenes@163.com （Sales Engineer）bkxc.bonnie@gmail.com

Scan the code to follow or search the official account on WeChat:

2D Materials Fronrier After paying attention,

click on the lower right corner to contact us,

Enter enterprise WeChat.

Professional Services Online

Nanomedicine

position： home > Nanomedicine > Nanomedicine - Tumors

source：material synthesis Views：2122time：2026-01-13material synthesis: 1092348845

已传文件：photo/1768289290.png

The efficacy of adoptive T-cell therapy (ACT) against solid tumors is significantly limited by the immunosuppressive tumor microenvironment (TME). Systemic administration of immunostimulants provides insufficient support to ACT cells and often induc

Next： Advanced Functional Ma Previous： The world is in an upr